Uncategorized Oppenheimer Reaffirms Outperform on Revolution Medicines, Cites PDAC and NSCLC Trial Progress Post Content
Uncategorized GitLab Maintains Buy Rating Despite Lowered Price Target, Shows Strong Seat Expansion Post Content
Uncategorized Cirsa’s Spanish IPO open to investors until July 7 in deal valuing it at nearly $3 billion Post Content
Uncategorized Thomson Reuters Announces Results of Early Tenders and Extension of Early Tender Time for Debt Exchange Offers and Consent Solicitations Post Content